The Abundance of the Long LSD1/KDM1a Isoform in Alcohol Treated Brains by Nanda, Ankit
THE ABUNDANCE OF THE LONG LSD1/KDM1A ISOFORM IN 
ALCOHOL TREATED BRAINS 
 
 
An Undergraduate Research Scholars Thesis 
by 
ANKIT NANDA 
 
 
Submitted to the Undergraduate Research Scholars program at  
Texas A&M University 
in partial fulfillment of the requirements for the designation as an 
 
 
UNDERGRADUATE RESEARCH SCHOLAR 
 
 
Approved by Research Advisor:  Dr. Michael C. Golding 
 
 
 
April 2019 
 
 
Major: Biomedical Sciences 
                 
TABLE OF CONTENTS 
 
Page 
ABSTRACT .................................................................................................................................. 1 
ACKNOWLEDGMENTS ............................................................................................................ 2 
NOMENCLATURE ..................................................................................................................... 3 
CHAPTER 
I. INTRODUCTION ...................................................................................................... 4 
Exon 8a of LSD1 .................................................................................................. 4 
What I Will Be Looking At .................................................................................. 4 
 
II. METHODS ................................................................................................................. 6 
Designing the Primers ........................................................................................... 6 
Figure 1 (3’ Primer Design) .................................................................................. 8 
Polymerase Chain Reaction .................................................................................. 8 
Gel Electrophoresis ............................................................................................... 9 
Data Collection ..................................................................................................... 9 
 
III. RESULTS ................................................................................................................. 10 
Figure 2 (Gel Electrophoresis Results) ............................................................... 10 
Gel Electrophoresis Result  ................................................................................. 10 
Data Analysis/Densitometry ............................................................................... 11 
Figure 3 (Graph Pad/Data Analysis Results) ...................................................... 12 
 
IV. CONCLUSION ......................................................................................................... 13 
REFERENCES ........................................................................................................................... 14 
  
1 
ABSTRACT 
The Abundance of the Long LSD1/Kdm1a Isoform in Alcohol Treated Brains 
 
 
Ankit Nanda 
Department of Veterinary Physiology and Pharmacology 
Texas A&M University 
 
 
Research Advisor: Dr. Michael C. Golding 
Department of Veterinary Physiology and Pharmacology 
Texas A&M University 
 
 
Alternative splicing is a eukaryotic mRNA processing mechanism in which exons within 
a pre-RNA transcript are joined differently or skipped entirely, yielding multiple protein 
isoforms from a single gene. This project studied the effect of alcohol treated brains in regards to 
alternative splicing of exon 8a in the Lysine-specific histone demethylase 1A (LSD1) gene. 
LSD1 is a flavin-dependent enzyme that demethylates mono or dimethylated lysines, and more 
specifically it removes histone H3K4me2 and changes it to either H3K4me1 or H3K4me0. The 
inclusion of exon 8a has been noted to create a docking site that helps the conversion of LSD1 
into H3K9 demethylase during neuronal differentiation. The expected outcome was that alcohol 
exposure alters the splicing of LSD1 and, thus, decreasing H3K9me2 activity. In this study, 
ethanol exposure was examined on neurospheres, which are culture systems clusters of neural 
stem cells, under control, 0.16 g/dL, and 0.24 g/dL alcohol conditions. Based off of the obtained 
data there was no clear indication that the inclusion or exclusion of Exon 8a affected the intensity 
of LSD1 gene expression with increasing levels of alcohol concentration. Rather, it seems that 
the increasing alcohol concentration overall correlated with a decreasing number of copies 
amplified of the LSD1 gene during PCR, regardless of the inclusion or exclusion of Exon 8a. 
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NOMENCLATURE  
 
LSD1  Lysine-specific histone demethylase 1a 
KDM1  Lysine (K)-specific demethylase 1a 
PCR  Polymerase Chain Reaction 
BLAST Basic Local Alignment Search Tool 
cDNA  Complementary DNA 
 
EtOH  Ethanol 
 
H3K9me2 Histone 3 Lysine 9 dimethylated  
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CHAPTER I 
INTRODUCTION 
 
Lysine-specific histone demethylase 1A (LSD1), also known as lysine (K)-specific 
demethylase 1A (KDM1a) in Mus musculus, is a flavin-dependent enzyme that demethylates 
mono or dimethylated lysines. LSD1 specifically demethylates histone H3K4me2 and changes it 
to either H3K4me1 or H3K4me0. LSD1 has been noted to have critical roles in embryogenesis 
and oocyte growth, as well as an important role in the epigenetic reprogramming that happens 
when sperm and an egg combine to form a zygote. Deletion of the gene for LSD1 can have 
effects on the growth and differentiation of embryonic stem cells. There is also some thought that 
high LSD1 levels are noted in relevance with cancer, so this may be a possible treatment outlook 
for cancer.  
Exon 8a of LSD1 
This project will be looking specifically at exon 8a of the LSD1/KDM1a gene. The 
inclusion of exon 8a has been noted to create a docking site that helps the conversion of LSD1 
into H3K9 demethylase during neuronal differentiation. Another study has reported that exon 8a 
functions as a H4K20 demethaylase (not H3K9), and it promotes transcriptional and elongation 
of neuronal activity-related genes by removing H4K20. This function of LSD1 is required for 
spatial learning and memory.  
What I Will Be Looking At 
My project will be looking at the effect of inclusion and exclusion of Exon 8a in the LSD1 gene 
on alcohol-treated neurospheres. A neurosphere is a culture system of clusters of neural stem 
cells; these will be used as the test cells under control, 0.16 g/dL, and 0.24 g/dL alcohol 
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conditions. I will be using the NCBI website to obtain the sequence of LSD1 and determine the 
position of exon 8a. From there, I will create two Common (forward) primers and will develop 
two reverse primers (one including exon 8a, one excluding). Then, I will perform a series of 
control and experimental samples in different combinations of the forward and reverse primers 
via Polymerase Chain Reaction (PCR) and Gel Electrophoresis. Finally, I will use ImageJ to 
collect data from the gel images of said samples and will analyze this data using GraphPad and 
the Sidak comparison test.  
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CHAPTER II 
METHODS 
 
All animal procedures were approved and conducted in accordance with the Institutional 
Animal Care and Use Committee at the Texas A&M College of Veterinary Medicine (protocol 
number 201-0308) and the Texas A&M University Institutional Biosafety Committee (protocol 
number 2015-100). Groups of Mus musculus (house mice) were monitored and used to obtain 
samples for this experiment. Cells from these mice were cultured as neurospheres to be used for 
the experiment and were preserved and incubated at 37°C. The treatment groups were treated in 
mediums containing: 0 g/dL, 0.16 g/dL, and 0.24 g/dL ethanol concentrations; 0 g/dL being the 
control treatment group, while 0.16 g/dL and 0.24 g/dL were used for the alcohol treatment 
groups. These samples were treated for up to 7 days, while obtaining samples at Day 3 and Day 
7. Aliquots were taken from these samples after the treatments were complete. These samples 
were set aside to be used later, with the designed forward and reverse primers, as the 
complementary-DNA (cDNA) in the Polymerase Chain Reaction procedures. 
Designing the Primers 
 After the samples were treated and obtained for later experiments, the forward and 
reverse primers were designed. Using the National Center of Biotechnology Information’s Gene 
Website [4], two isoform nucleotide sequences of the Lysine (K)-specific demethylase 1a 
(Kdm1a) gene were obtained. After the two isoform nucleotide sequences were obtained, the 
National Center of Biotechnology Information’s Basic Local Alignment Search Tool (BLAST) 
[5] was used. This tool finds regions of similarity between multiple biological sequences and will 
compare these sequences with other sequence databases. The nucleotide sequences of the two 
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isoforms yielded a long, singular nucleotide sequence after being aligned. From this singular 
nucleotide sequence, the exact location of Exon E8a was determined. Exon E8a was determined 
to be approximately twelve nucleotides long. Based off of this location and information, a 
forward primer nucleotide sequence was determined: TGGAAGCCAGGGATCGAGTA. This 
forward primer was determined to be a common forward primer, which would be used in 
conjunction with both reverse primers that were designed. Using the nucleotide sequence, two 
reverse primers were designed around the position of Exon E8a, as shown in Figure 1. The first 
was a 22 nucleotide long sequence that contained Exon E8a (12 nucleotides long). This primer 
was designed to have the sequence: GGAACCTTGACAGTGTCAGCTT. The second reverse 
primer was a 24 nucleotide long sequence that did contain Exon E8a. This primer spanned the 
splice junction between Exons 7 and 9. This primer was designed to have the sequence: 
TCTTTTGGAACAGCTTGTCCATTG. These primers were ordered from Invitrogen to be 
tested.  
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Figure 1. (a) Exon 8 Included Reverse Primer Design. 22 nucleotide long reverse primer 
(GGAACCTTGACAGTGTCAGCTT) designed to be paired with a common forward primer 
(TGGAAGCCAGGGATCGAGTA). Used to measure the intensity of increasing alcohol 
exposure, with the inclusion of LSD1 gene Exon 8a, on neurosphere cells. (b) Exon 8 Excluded 
Reverse Primer Design. 24 nucleotide long reverse primer 
(TCTTTTGGAACAGCTTGTCCATTG) designed to be paired with a common forward primer 
(TGGAAGCCAGGGATCGAGTA). Used to measure the intensity of increasing alcohol 
exposure, with the exclusion of LSD1 gene Exon 8a on neurosphere cells. 
 
Polymerase Chain Reaction (PCR) 
 After the designed primers arrived to the lab, they were ready to be tested on the cDNA 
samples that were obtained from the alcohol treated neurospheres. It was determined that a PCR 
would help amplify the interaction between the cDNA and the forward/reverse primers. Firstly, 
the cDNA aliquots were diluted in a mixture with water. 3 uL of cDNa were added into 69 uL of 
distilled H2O, yielding a concentration of 0.625 ng/uL. Using this diluted cDNA, a 20 uL PCR 
reaction sample was created containing: 10 uL of PCR Master Mix (PCR buffer, dNTP, PCR 
enzyme, and a salt compound), 1 uL forward primer (common), 1 uL reverse primer (including 
or excluding Exon E8a), and 8 uL premade H2O and cDNA mix (0.35 uL cDNA, 7.65 uL H2O). 
The PCR experiments were run at 60°C for 36 cycles. The PCR experiments were conducted for 
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Figure 2. (a) Exon 8 Included Gel Electrophoresis Result. Visualization using 
Ethidium Bromide (EtBr) in UV-based imaging system. Gel Electrophoresis 
was performed on 2% agarose gel at 90V for approximately 27 minutes. (b) 
Exon Excluded Gel Electrophoresis Results. Same conditions as described in 
(a). For all gels: the samples on the top row were conducted using Day 3 cDNA 
PCR product and the samples on the bottom row were conducted using Day 7 
cDNA. For all gels, wells 1 & 2 at 0.00 g/dL EtOH concentration, wells 3 & 4 at 
0.16 g/dL EtOH concentration, and wells 5 & 6 at 0.24 g/dL EtOH 
concentration.  
Lysine-specific histone demethylase 1A (LSD1), also known 
as lysine (K)-specific demethylase 1A (KDM1a) in Mus 
musculus, is a flavin-dependent enzyme that demethylates 
mono or di-methylated lysines. LSD1 specifically 
demethylates di-methylated Histone H3 Lysine 9 and changes 
it to either H3K9me1 or H3K9me0. LSD1 has been noted to 
have critical roles in embryogenesis and oocyte growth, as 
well as an important role in the epigenetic reprogramming 
that happens when sperm and an egg combine to form a 
zygote. Deletion of the gene for LSD1 can have effects on the 
growth and differentiation of embryonic stem cells. There is 
also some thought that high LSD1 levels are noted in 
relevance with cancer, so this may be a possible treatment 
outlook for cancer.  
 
This project will be looking specifically at exon 8a of the 
LSD1/KDM1a gene. The inclusion of exon 8a has been noted 
to create a docking site that helps the conversion of LSD1 
into Histone 3 Lysine 9 demethylase during neuronal 
differentiation. We will be looking at the effect of inclusion 
and exclusion of Exon 8a in the LSD1 gene on alcohol-
treated neurospheres, which are culture systems of neural 
stem cells. These will be used as the test cells under 0.00 g/
dL, 0.16 g/dL, and 0.24 g/dL alcohol conditions.  
 
The NCBI website will be used to obtain the sequence of the 
LSD1 gene and determine the position of Exon 8a. From this, 
a common forward primer and two reverse primers will be 
designed to test the inclusion and exclusion of Exon 8a.  
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•  Alcohol Treatment (7 days) 
•  RNA Extraction (Day 3 and Day 7) 
•  cDNA Synthesis 
•  Primer Design (Figure 1) 
•  Real Time - Polymerase Chain Reaction (RT-PCR) 
at 60°C for 36 cycles  
•  Gel Electrophoresis/UV Visualization (Figure 2) 
•  Data Collection using ImageJ 
•  Data Analysis using GraphPad (Sidak comparison 
test, Figure 3) 
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Figure 3. Comparison of LSD1 Exon 8a inclusion and exclusion in Control (0.00 g/dL) 
and Ethanol (0.16 g/dL and 0.24 g/dL) treated neurospheres, both during the period of 
exposure (Day 3) and after a 4-day recovery period (Day 7) (a) Data for increasing 
alcohol exposure with Exon 8 included. No statistical significance was determined 
between Day 3 control vs. 0.16 g/dL EtOH data, Day 3 0.16 g/dL vs. 0.24 g/dL EtOH 
data, Day 7 control vs. 0.16 g/dL EtOH data, Day 7 control vs. 0.24 g/dL EtOH data, 
and Day 7 0.16 g/dL vs. .24 g/dL EtOH data. There was statistical significance 
determined between Day 3 control vs. 0.24 g/dL EtOH data. (b) Data for increasing 
alcohol exposure with Exon 8 excluded. No statistical significance was determined 
between Day 3 0.16 g/dL vs. 0.24 g/dL EtOH data, Day 7 control vs. 0.16 g/dL EtOH 
data, and Day 7 0.16 g/dL vs. 0.24 g/dL EtOH data. There was statistical significance 
determined between Day 3 control vs. 0.16 g/dL EtOH data, Day 3 control vs. 0.24 g/dL 
EtOH data, and Day 7 control vs. 0.24 g/dL EtOH data. 
Based off the results shown in Figure 3, there was 
no clear indication that the inclusion or exclusion 
of Exon 8a affected the intensity of LSD1 gene 
expression with increasing levels of alcohol 
concentration. Rather, it seems that the increasing 
alcohol concentration overall correlated with a 
decreasing number of copies amplified of the 
LSD1 gene duri g PCR, regardless of the 
inclusion or exclusion of Exon 8a. 
I would like to thank Janie McGlohon, Richard 
Chang, Yudi Bedi, Dr. Michael C. Golding and all 
other members of the Reproductive Sciences Lab 
who have helped and contributed to this project.  
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each combination of common forward primer with the reverse primer including Exon E8a and 
common forward primer with the reverse primer excluding Exon E8a. These experiments were 
repeated due to the initial gel images not being clear. 
Gel Electrophoresis 
 After the PCR experiments were completed at 60°C and 36 cycles, the obtained samples 
needed to be visualized to see the final results. It was determined that gel electrophoresis would 
provide a good visualization of the PCR experiments. Gel electrophoresis was performed at 90 
volts for approximately 27 minutes, and the resulting gel was visualized using a UV-based 
imaging system under the ethidium bromide imaging tag.  
Data Collection 
 After all PCR experiments were visualized using gel electrophoresis and the UV-based 
imaging system, the obtained pictures were copied into a flash drive. These pictures were then 
loaded up on a computer containing the program ImageJ. It was determined that this program 
would help collect data from these images. Using basic measurement setting on ImageJ, the 
intensity of each gel background was measured as a control average. Then, the intensity of each 
well was determined. The average of the background intensity was subtracted from each specific 
well’s intensity to determine its intensity ratios. These numbers were collected in an excel 
spreadsheet for further analysis. Finally, the program GraphPad was used to import all numbers 
regarding the intensity of the control and alcohol treatment samples. These results were graphed 
and were used in a Sidak comparison test: control vs. alcohol (0.16 g/dL), control vs. alcohol 
(0.24 g/dL), and alcohol (0.16 g/dL) vs. alcohol (0.24 g/dL). The results between these were 
charted and were determined to be either significant or not at an alpha = 0.05 significance level.  
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CHAPTER III 
RESULTS 
 
 Using the aforementioned methods, polymerase chain reaction was performed for two 
samples: common primer + included exon 8a reverse primer and common primer + excluded 
exon 8a reverse primer. The obtained samples from the PCR were then visualized using gel 
electrophoresis, as shown in Figure 2 below. 
 
 
 
Figure 2. (a) Exon 8 Included Gel Electrophoresis Result. Visualization using Ethidium 
Bromide (EtBr) in UV-based imaging system. Gel Electrophoresis was performed on 2% agarose 
gel at 90V for approximately 27 minutes. (b) Exon Excluded Gel Electrophoresis Results. 
Same conditions as described in (a). For all gels: the samples on the top row were conducted 
using Day 3 cDNA PCR product and the samples on the bottom row were conducted using Day 
7 cDNA. For all gels, wells 1 & 2 at 0.00 g/dL EtOH concentration, wells 3 & 4 at 0.16 g/dL 
EtOH concentration, and wells 5 & 6 at 0.24 g/dL EtOH. 
 
Gel Electrophoresis Result 
The combination of the common forward primer and the exon 8a included reverse primer 
is shown in Figure 2a. From the top row (Day 3), it can be seen that the intensity of the wells in 
the image gradually decreased as the concentration of alcohol treatment increased. There was 
also no visualization obtained for wells 5 & 6, which denoted the treatment of 0.24 g/dL EtOH. 
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Figure 2. (a) Exon 8 Included Gel Electrophoresis Result. Visualization using 
Ethidium Bromide (EtBr) in UV-based imaging system. Gel Electrophoresis 
was performed on 2% agarose gel at 90V for approximately 27 minutes. (b) 
Exon Excluded Gel Electrophoresis Results. Same conditions as described in 
(a). For all gels: the samples on the top row were conducted using Day 3 cDNA 
PCR product and the samples on the bottom row were conducted using Day 7 
cDNA. For all gels, wells 1 & 2 at 0.00 g/dL EtOH concentration, wells 3 & 4 at 
0.16 g/dL EtOH concentration, and wells 5 & 6 at 0.24 g/dL EtOH 
concentration.  
Lysine-specific histone demethylase 1A (LSD1), also known 
as lysine (K)-specific demethylase 1A (KDM1a) in Mus 
musculus, is a flavin-dependent enzyme that demethylates 
mono or di-methylated lysines. LSD1 specifically 
demethylates di-methylated Histone H3 Lysine 9 and changes 
it to either H3K9me1 or H3K9me0. LSD1 has been noted to 
have critical roles in embryogenesis and oocyte growth, as 
well as an important role in the epigenetic reprogramming 
that happens when sperm and an egg combine to form a 
zygote. Deletion of the gene for LSD1 can have effects on the 
growth and differentiation of embryonic stem cells. There is 
also some thought that high LSD1 levels are noted in 
relevance with cancer, so this may be a possible treatment 
outlook for cancer.  
 
This project will be looking specifically at exon 8a of the 
LSD1/KDM1a gene. The inclusion of exon 8a has been noted 
to create a docking site that helps the conversion of LSD1 
into Histone 3 Lysine 9 demethylase during neuronal 
differentiation. We will be looking at the effect of inclusion 
and exclusion of Exon 8a in the LSD1 gene on alcohol-
treated neurospheres, which are culture systems of neural 
stem cells. These will be used as the test cells under 0.00 g/
dL, 0.16 g/dL, and 0.24 g/dL alcohol conditions.  
 
The NCBI website will be used to obtain the sequence of the 
LSD1 gene and determine the position of Exon 8a. From this, 
a common forward primer and two reverse primers will be 
designed to test the inclusion and exclusion of Exon 8a.  
(a)& (b)&
(a)& (b)&
•  Alcohol Treatment (7 days) 
•  RNA Extraction (Day 3 and Day 7) 
•  cDNA Synthesis 
•  Primer Design (Figure 1) 
•  Real Time - Polymerase Chain Reaction (RT-PCR) 
at 60°C for 36 cycles  
•  Gel Electrophoresis/UV Visualization (Figure 2) 
•  Data Collection using ImageJ 
•  Data Analysis using GraphPad (Sidak comparison 
test, Figure 3) 
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Figure 1. (a) Exon 8 Included Reverse Primer Design. 22 nucleotide long 
reverse primer (GGAACCTTGACAGTGTCAGCTT) designed to be paired with 
a common forward primer (TGGAAGCCAGGGATCGAGTA). Used to measure 
the intensity of increasing alcohol exposure, with the inclusion of LSD1 gene 
Exon 8a, on neur sphere cells. (b) Exon 8 Excluded Reverse Primer Design. 24
nucleotide long reverse primer (TCTTTTGGAACAGCTTGTCCATTG) designed 
to be paired with a common forward primer (TGGAAGCCAGGGATCGAGTA). 
Used to measure the intensity of increasing alcohol exposure, with the exclusion 
of LSD1 gene Exon 8a on neurosphere cells. 
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Figure 3. Comparison of LSD1 Exon 8a inclusion and exclusion in Control (0.00 g/dL) 
and Ethanol (0.16 g/dL and 0.24 g/dL) treated neurospheres, both during the period of 
exposure (Day 3) and after a 4-day recovery period (Day 7) (a) Data for increasing 
alcohol exposure with Exon 8 included. No statistical significance was determined 
between Day 3 control vs. 0.16 g/dL EtOH data, Day 3 0.16 g/dL vs. 0.24 g/dL EtOH 
data, Day 7 control vs. 0.16 g/dL EtOH data, Day 7 control vs. 0.24 g/dL EtOH data, 
and Day 7 0.16 g/dL vs. .24 g/dL EtOH data. There was statistical significance 
determined between Day 3 control vs. 0.24 g/dL EtOH data. (b) Data for increasing 
alcohol exposure with Exon 8 excluded. No statistical significance was determined 
between Day 3 0.16 g/dL vs. 0.24 g/dL EtOH data, Day 7 control vs. 0.16 g/dL EtOH 
data, and Day 7 0.16 g/dL vs. 0.24 g/dL EtOH data. There was statistical significance 
determined between Day 3 control vs. 0.16 g/dL EtOH data, Day 3 control vs. 0.24 g/dL 
EtOH data, and Day 7 control vs. 0.24 g/dL EtOH data. 
Based off the results shown in Figure 3, there was 
no clear indication that the inclusion or exclusion 
of Exon 8a affected the intensity of LSD1 gene 
expression with increasing levels of alcohol 
concentration. Rather, it seems that the increasing 
alcohol concentration overall correlated with a 
decreasing number of copies amplified of the 
LSD1 gene duri g PCR, regardless of the 
inclusion or exclusion of Exon 8a. 
I would like to thank Janie McGlohon, Richard 
Chang, Yudi Bedi, Dr. Michael C. Golding and all 
other members of the Reproductive Sciences Lab 
who have helped and contributed to this project.  
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From the bottom row (Day 7), it can be seen that the intensity of the wells fluctuated; however, 
with an overall decrease in intensity as concentration of alcohol treatment increased. The 
combination of the common forward primer and the exon 8a excluded reverse primer is shown in 
Figure 2b. From the top row (Day 3), it can be seen the intensity of the wells in the image 
gradually decreased as the concentration of alcohol treatment increased. From the bottom row 
(Day 7), it can also been seen that the intensity of the wells gradually decreased as the 
concentration of alcohol treatment increased.  
Data Analysis/Densitometry 
 The obtained gel electrophoresis images were uploaded to a densitometry program, 
ImageJ, and intensity data of the wells was measured using its measurement tool. The data was 
further analyzed and significance was determined using Holm-Sidak’s multiple comparison tests. 
The obtained data is shown in Figure 3 below.  
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Figure 3. Comparison of LSD1 Exon 8a inclusion and exclusion in Control (0.00 g/dL) and 
Ethanol (0.16 g/dL and 0.24 g/dL) treated neurospheres, both during the period of exposure (Day 
3) and after a 4-day recovery period (Day 7) (a) Data for increasing alcohol exposure with 
Exon 8 included. No statistical significance was determined between Day 3 control vs. 0.16 
g/dL EtOH data, Day 3 0.16 g/dL vs. 0.24 g/dL EtOH data, Day 7 control vs. 0.16 g/dL EtOH 
data, Day 7 control vs. 0.24 g/dL EtOH data, and Day 7 0.16 g/dL vs. 0.24 g/dL EtOH data. 
There was statistical significance determined between Day 3 control vs. 0.24 g/dL EtOH data. 
(b) Data for increasing alcohol exposure with Exon 8 excluded. No statistical significance 
was determined between Day 3 0.16 g/dL vs. 0.24 g/dL EtOH data, Day 7 control vs. 0.16 g/dL 
EtOH data, and Day 7 0.16 g/dL vs. 0.24 g/dL EtOH data. There was statistical significance 
determined between Day 3 control vs. 0.16 g/dL EtOH data, Day 3 control vs. 0.24 g/dL EtOH 
data, and Day 7 control vs. 0.24 g/dL EtOH data. 
 
 The obtained data for the combination of the common forward primer and the exon 8a 
included reverse primer are shown in Figure 3a. As seen from the chart, there was an overall 
decrease in intensity in both Days 3 and 7 as the alcohol concentration increased. As there was 
no intensity detected for wells 5 & 6 during Day 3, the data was listed as ND or not detectable. 
There was a statistical significance noted between control vs. 0.24 g/dL EtOH conditions on Day 
3. It was determined that the overall drop in intensity passed a certain threshold to be considered 
significant for that data. There was no statistical significance noted in the following comparisons: 
Day 3 control vs. 0.16 g/dL EtOH, Day 3 0.16 g/dL vs. 0.24 g/dL, Day 7 control vs. 0.16 g/dL 
EtOH, Day 7 control vs. 0.24 g/dL EtOH, and Day 7 0.16 g/dL vs. 0.24 g/dL. The obtained data 
for the combination of the common forward primer and the exon 8a excluded reverse primer are 
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Figure 2. (a) Exon 8 Included Gel Electrophoresis Result. Visualization using 
Ethidium Bromide (EtBr) in UV-based imaging system. Gel Electrophoresis 
was performed on 2% agarose gel at 90V for approximately 27 minutes. (b) 
Exon Excluded Gel Electrophoresis Results. Same conditions as described in 
(a). For all gels: the samples on the top row were conducted using Day 3 cDNA 
PCR product and the samples on the bottom row were conducted using Day 7 
cDNA. For all gels, wells 1 & 2 at 0.00 g/dL EtOH concentration, wells 3 & 4 at 
0.16 g/dL EtOH concentration, and wells 5 & 6 at 0.24 g/dL EtOH 
concentration.  
Lysine-specific histone demethylase 1A (LSD1), also known 
as lysine (K)-specific demethylase 1A (KDM1a) in Mus 
musculus, is a flavin-dependent enzyme that demethylates 
mono or di-methylated lysines. LSD1 specifically 
demethylates di-methylated Histone H3 Lysine 9 and changes 
it to either H3K9me1 or H3K9me0. LSD1 has been noted to 
have critical roles in embryogenesis and oocyte growth, as 
well as an important role in the epigenetic reprogramming 
that happens when sperm and an egg combine to form a 
zygote. Deletion of the gene for LSD1 can have effects on the 
growth and differentiation of embryonic stem cells. There is 
also some thought that high LSD1 levels are noted in 
relevance with cancer, so this may be a possible treatment 
outlook for cancer.  
 
This project will be looking specifically at exon 8a of the 
LSD1/KDM1a gene. The inclusion of exon 8a has been noted 
to create a docking site that helps the conversion of LSD1 
into Histone 3 Lysine 9 demethylase during neuronal 
differentiation. We will be looking at the effect of inclusion 
and exclusion of Exon 8a in the LSD1 gene on alcohol-
treated neurospheres, which are culture systems of neural 
stem cells. These will be used as the test cells under 0.00 g/
dL, 0.16 g/dL, and 0.24 g/dL alcohol conditions.  
 
The NCBI website will be used to obtain the sequence of the 
LSD1 gene and determine the position of Exon 8a. From this, 
a common forward primer and two reverse primers will be 
designed to test the inclusion and exclusion of Exon 8a.  
(a)& (b)&
(a)& (b)&
•  Alcohol Treatment (7 days) 
•  RNA Extraction (Day 3 and Day 7) 
•  cDNA Synthesis 
•  Primer Design (Figure 1) 
•  Real Time - Polymerase Chain Reaction (RT-PCR) 
at 60°C for 36 cycles  
•  Gel Electrophoresis/UV Visualization (Figure 2) 
•  Data Collection using ImageJ 
•  Data Analysis using GraphPad (Sidak comparison 
test, Figure 3) 
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Figure 1. (a) Exon 8 Included Reverse Primer Design. 22 nucleotide long 
reverse primer (GGAACCTTGACAGTGTCAGCTT) designed to be paired with 
a common forward primer (TGGAAGCCAGGGATCGAGTA). Used to measure 
the intensity of increasing alcohol exposure, with the inclusion of LSD1 gene 
Exon 8a, on neurosphere cells. (b) Exon 8 Excluded Reverse Primer Design. 24 
nucleotide long reverse primer (TCTTTTGGAACAGCTTGTCCATTG) designed 
to be paired with a common forward primer (TGGAAGCCAGGGATCGAGTA). 
Used to measure the intensity of increasing alcohol exposure, with the exclusion 
of LSD1 gene Exon 8a on neurosphere cells. 
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Figure 3. omparison of LSD1 Exon 8a inclusion and exclusion in Control (0.00 g/dL) 
and Ethanol (0.16 g/dL and 0.24 g/dL) treated neur s res, both during the period f 
exposure (D y 3) nd after a 4-day recovery period ( y 7) (a) Data for increasing 
alcohol exposure with Exon 8 included. No statistical significance was determined 
between Day 3 control vs. 0.16 g/dL EtOH data, Day 3 0.16 g/dL vs. 0.24 g/dL EtOH 
data, a   trol vs. 0.16 g/dL EtOH data, Day 7 control vs. 0.24 g/dL EtOH data, 
and Day 7 0.16 g/dL vs. .24 g/dL EtOH data. There was statistical significance 
determined between Day 3 control vs. 0.24 g/dL EtOH data. (b) Data for increasing 
alcohol exposure with Exon 8 excluded. No statistical significance was determined 
between Day 3 0.16 g/dL vs. 0.24 g/dL EtOH data, Day 7 control vs. 0.16 g/dL EtOH 
data, and Day 7 0.16 g/dL vs. 0.24 g/dL EtOH data. There was statistical significance 
determined between Day 3 control vs. 0.16 g/dL EtOH data, Day 3 control vs. 0.24 g/dL 
EtOH data, and Day 7 control vs. 0.24 g/dL EtOH data. 
Based off the results shown in Figure 3, there was 
no clear indication that the inclusion or exclusion 
of Exon 8a affected the intensity f LSD1 ene 
expression with increasing levels of alcohol 
concentration. Rather, it seems that the increasing 
alcohol concentration overall correlated with a 
decreasing number of copies amplified of the 
LSD1 gene duri g PCR, regardless of the 
inclusion or exclusion of Exon 8a. 
I would like to thank Janie McGlohon, Richard 
Chang, Yudi Bedi, Dr. Michael C. Golding and all 
other members of the Reproductive Sciences Lab 
who have helped and contributed to this project.  
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shown in Figure 3b. As seen from the chart, there was an overall decrease in intensity in both 
Days 3 and 7 as the alcohol concentration increased. There was statistical significances noted in 
the following data comparisons: Day 3 control vs. 0.16 g/dL EtOH, Day 3 control vs. 0.24 g/dL 
EtOH, and Day 7 control vs. 0.24 g/dL EtOH. It was determined that the overall drop in intensity 
between these sets of data passed a certain threshold to be considered significant. There was no 
statistical significance noted in the following data comparisons: Day 3 0.16 g/dL vs. 0.24 g/dL 
EtOH, Day 7 control vs. 0.16 g/dL EtOH, and Day 7 0.16 g/dL vs. 0.24 g/dL EtOH. 
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CHAPTER IV 
CONCLUSION 
 
As mentioned previously, the expected outcome of the project was that alcohol exposure 
alters the splicing of LSD1 and, thus, decreasing H3K9me2 activity. The purpose of the project 
was to determine whether the inclusion or exclusion of Exon 8a, in the presence of increasing 
alcohol concentration, alters H3K9me2 activity, positively or negatively. However, based off the 
results shown in Figure 3, there was no clear indication that the inclusion or exclusion of Exon 
8a affected the intensity of LSD1 gene expression with increasing levels of alcohol 
concentration. Rather, the data shows that the increasing alcohol concentration overall correlated 
with a decreasing number of copies amplified of the LSD1 gene during PCR, regardless of the 
inclusion or exclusion of Exon 8a. This means that increasing alcohol concentration directly 
affects the LSD1 gene amplification during PCR, but the inclusion or exclusion of Exon 8a does 
not affect the intensity drastically in any way. As mentioned before, there is also some thought 
that high LSD1 levels are noted in relevance with cancer. This may be a possible treatment 
outlook for cancer and a further implication of this project.  
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